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Abstract
Background: The reasons of deaths in developing countries are shifting from communicable diseases towards
non-communicable diseases (NCDs). At the same time the number of health care interventions using mobile
phones (mHealth interventions) is growing rapidly. We review studies assessing the health-related impacts of
mHealth on NCDs in low- and middle-income countries (LAMICs).
Methods: A systematic literature search of three major databases was performed in order to identify randomized
controlled trials (RCTs) of mHealth interventions. Identified studies were reviewed concerning key characteristics of
the trial and the intervention; and the relationship between intervention characteristics and outcomes was
qualitatively assessed.
Results: The search algorithms retrieved 994 titles. 8 RCTs were included in the review, including a total of 4375
participants. Trials took place mostly in urban areas, tested different interventions (ranging from health promotion
over appointment reminders and medication adjustments to clinical decision support systems), and included
patients with different diseases (diabetes, asthma, hypertension). Except for one study all showed rather positive
effects of mHealth interventions on reported outcome measures.
Furthermore, our results suggest that particular types of mHealth interventions that were found to have positive effects
on patients with communicable diseases and for improving maternal care are likely to be effective also for NCDs.
Conclusions: Despite rather positive results of included RCTs, a firm conclusion about the effectiveness of mHealth
interventions against NCDs is not yet possible because of the limited number of studies, the heterogeneity of
evaluated mHealth interventions and the wide variety of reported outcome measures. More research is needed to
better understand the specific effects of different types of mHealth interventions on different types of patients with
NCDs in LaMICs.
Background
As a result of increasing life-expectancy and growing
welfare in low and middle income countries (LaMICs),
there is a steady shift away from communicable to non-
communicable diseases (NCDs) [1–3]. NCDs pose a
major threat to public health in LaMICs. In 2010, NCDs
already accounted for half of Disability Adjusted Life
Years (DALYs) lost and for 58 % of all deaths in these
countries [4]. It is predicted that this number will in-
crease to 70 % of all deaths in 2020 [5]. The economic
cost of the NCDs burden for LaMICs are estimated to
reach US$21 trillion by 2030 [3].
The ability of LaMICs to provide treatment and care
for the increasing number of patients with NCDs is lim-
ited by insufficient health care infrastructure, especially
in rural areas [6]. At the same time there is a rapidly
growing, hidden infrastructure: 90 % of the world’s
population now lives within reach of a mobile phone
signal [7] and the developing world has the fastest-
growing cellphone subscriber market in the world [8, 9]
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with a mobile-cellular subscription rate of almost
90 % in 2013 [10].
The number of health care interventions using mobile
phones (short mHealth interventions) is growing rapidly
[11]. In particular in LaMICs, mHealth is perceived to
have great potential for improving health care provision
for both communicable and non-communicable diseases
[12]. Most of the available literature on mHealth inter-
ventions is focused on communicable diseases (such as
HIV and Malaria) or on maternal care [13]. However,
the number of studies focusing on mHealth for patients
with NCDs has considerably increased over the last few
years. In fact, two thirds of all articles on the topic have
been published between 2012 and 2015 (based on a
Web of Science search with the keywords TS = (mHealth
OR “mobile Health” or tele*) AND TS = (“developing”)
AND TS = (NCD OR “non-communicable diseases”).
Yet, evaluations of mheatlh interventions often do not fol-
low rigorous scientific standards of randomized controlled
trials (RCTs), and consequently, they carry a relatively
high risk of bias [14].
Two reviews are available that have included studies
analyzing certain aspects of mHealth interventions for
NCDs in LaMICs: Beratarrechea et al. [15] evaluated
text and automated voice interventions for chronic dis-
eases in the developing world and Bloomfield et al. [16]
performed a review of mHealth interventions against
NCDs focusing only on Sub-Saharan African countries.
However, as Beratarrechea et al. [15] did not focus
specifically on NCDs and because Bloomfield et al.
[16] focused exclusively on Sub-Saharan Africa, a
comprehensive overview of the effectiveness of
mHealth interventions for improved treatment and
care of patients with NCDs living in LaMICs remains
unavailable.
The aim of this study was 1) to systematically review
the available evidence generated by randomized controlled
trials (RCTs) of mHealth interventions for people with
NCDs living in LaMICs, and 2) to assess the relationship
between intervention characteristics and reported health-
related outcomes. We focused on RCTs since they remain
the gold standard for evidence of effectiveness of health
interventions [17].
Method
Inclusion criteria
Studies were included for this review if they met the fol-
lowing inclusion criteria:
 The study reported results of an RCT, as defined by
JN Matthews [18]
 The trial took place in at least one country that was
classified as an LaMIC as defined by the World
Bank classification of country income groups [19]
 The intervention involved the use of mHealth as
defined by the Global Observatory for eHealth [11]
 Trial participants were patients suffering from
NCDs as defined by the WHO [20]
 The study was published in English or German
 The study was published before August 2015 (no
limit concerning the start date)
Literature search method
An initial systematic literature search was performed be-
tween December 2013 and February 2014 in MEDLINE
(PubMed), CENTRAL and Business Source Complete.
An update of the search was performed in August 2015.
After piloting appropriate search words, the terms
were constructed around (1) “mHealth”, (2) “Low and
Middle Income Countries” and (3) “Non Communicable
Disease”. Search terms for the operationalization of
NCDs were derived from WHO’s Global Burden of Dis-
ease Report. In addition to the medical terms specified
in the Global Burden of Disease Report (e.g., myocardial
infarction or dermatological cancer), we added more
common terms such as heart or skin (for including in-
terventions against skin cancer) to the search algorithm.
The search conducted in CENTRAL is shown in the
Additional file 1: Table S1. It was carried out using the
free text search with Boolean operators and MeSH de-
scriptors using the terms Telemedicine [MeSH] AND
Developing Countries [MeSH] (with no filter for diseases
and the enabled option of exploding all trees). The same
search-approach was applied using MEDLINE. Due to a
low number of results in the database Business Source
Complete it was feasible to exclude the field of terms for
NCDs and to include solely the location and interven-
tion of interest.
In addition, reference lists of included studies and
identified existing reviews were screened for relevant
titles.
After removal of duplicates, the resulting list of titles
(Medline 730, CENTRAL 116, Business Source
Complete 125) was screened and studies whose titles/
abstracts clearly indicated that they were not con-
cerned with mHealth intervention trials for NCDs in
LaMICs (e.g., if titles indicated that they focused on
developed countries or HIV) were excluded from fur-
ther consideration.
Full-text articles of 114 studies were retrieved and
assessed, resulting in 8 articles included for this review.
The screening process was conducted independently by
two reviewers (VS and DO). Disagreements were dis-
cussed between authors and resolved by consensus.
Data collection and analysis
For each included study, information was collected on
key characteristics of the RCTs concerning:
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1) the study location (country, urban/rural);
2) the population (disease, inclusion and exclusion
criteria for trial participants);
3) the intervention characteristics, including
information on the type of mHealth intervention
(e.g., text message, phone call), the data transmitted
(e.g., appointment reminders, advice and medication
reminders), interactivity of the intervention (i.e.,
whether it was possible for patients or providers to
respond to information received), and
personalization (i.e., whether timing or content of
information were specific for the patient);
4) the comparator (control) group intervention (e.g.,
booklet with information on asthma instead of text
message with information); and
5) outcomes reported by the studies, including clinical
outcomes, compliance, quality of life, costs and
other outcomes.
In order to assess the relationship between interven-
tion characteristics and outcomes, studies were catego-
rized into one of four types of mHealth interventions as
suggested by Howitt et al. [21] (with slight modifica-
tions). We distinguished between interventions for 1)
health promotion & awareness, 2) remote monitoring &
care support, 3) disease surveillance & outbreak detec-
tion, and 4) decision support system.
Meta-analytic techniques were not employed because
differences between studies concerning the type of inter-
vention, the included study participants (different dis-
eases), and the reported outcome measures (clinical
outcomes, compliance, etc.) made a meaningful analysis
of pooled data impossible.
Risk of bias
Risk of bias was assessed qualitatively concerning selec-
tion bias (sequence generation and allocation sequence
concealment), performance bias (blinding of participants
and personnel), detection bias (blinding of outcome as-
sessment), extent of loss to follow-up, reporting bias (se-
lective outcome reporting), and other bias (e.g.,
imbalance in baseline characteristics). We used the
Cochrane Collaboration’s tool for assessing risk of bias
and information on assessment were derived from the
text [22]. The full risk assessment of the included studies
is available in the Additional file 2.
Results
Literature search results
Figure 1 illustrates the literature search and selection
process, and presents reasons for exclusion of studies.
We identified a total of 969 studies in the three data-
bases and 23 studies were retrieved from references
of other studies. Full texts of 114 studies were
screened of which 106 were excluded, mostly because
they did not deal with mHealth (n = 43), did not re-
port results of an RCT (n = 25), did not take part in
LaMICs (n = 13) or because of other reasons (n = 25).
The final analysis included 8 studies, which met all
inclusion criteria.
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Fig. 1 Overview of the screening process
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Characteristics of included studies
Trial characteristics
Table 1 summarizes the main characteristics of the eight
included trials. Five studies were conducted in lower
middle income countries (LMICs), three in upper middle
income countries (UMICs). Two studies [23, 24] re-
ported results of trials, which included patients in both a
LMIC and a UMIC (Mexico and Honduras, and India
and China, respectively). The participating patients came
mostly from urban areas and were recruited mainly from
primary care centers or urban hospitals. Three studies
dealt with diabetes [25–27], two with asthma patients
[28, 29], two with patients suffering from cardiovascular
diseases, [23, 24] and one with patients having different
NCDs [30], including hypertension, asthma and diabetes.
A total of 4375 participants were included in all eight
studies, of whom 2095 received a mHealth intervention,
314 received an alternative landline-telephone based
intervention, and 1966 were included in the control
group. Trial size varied from 16 participants [29] to
2086 participants [24]. The mean age in the intervention
group was 57.2 years and in the control group 57.8 years.
Studies reported a wide range of outcomes, which were
classified for the purposes of our review into disease spe-
cific clinical outcomes, compliance and others.
Intervention characteristics
Table 2 provides an overview about the main character-
istics of the mHealth interventions that were evaluated
in the eight RCTs. Two interventions informed patients
with diabetes about the management of the disease and
gave general advice on a healthy lifestyle (category health
promotion & awareness): One informed the participants
through an internet webpage and frequently sent text
messages [25], while the other sent a text message once
in three days to the study participants [26]. Both inter-
ventions were not personalized to the participants and
not interactive.
The most basic intervention in the category of remote
monitoring & care support was an appointment-
reminder system, where text messages were sent 24–48
h before the patients’ scheduled appointments [30].
Four interventions required the patients to record key
parameters of their disease, e.g., the Peak Expiratory
Flow Rate (PEFR) for patients with Asthma [28, 29], the
blood glucose level for patients with Diabetes [27] or the
blood pressure for patients with hypertension [23]. They
did so by using additional devices (home blood pressure
monitor, glucometer, peak expiratory flow meter) and
the patients were then asked to send this data either via
a text message to a physician [29], to type their records
into an interactive phone software [28] or they were
called by a specialist and transmitted the information via
a phone-call [23, 27]. In all the four studies, patients re-
ceived personalized disease-management advice.
Only one intervention fell into the category of clinical
decision support systems [24]. Community health
workers (CHWs) treating patients with cardiovascular
diseases in rural areas received a smartphone with an
application consisting of prompts regarding the patients’
clinical values, adherence to treatment and other param-
eters. The application was tailored to the local customs.
Results of the RCTs
Table 3 provides an overview of all relevant outcomes
reported by the eight included studies, illustrating sig-
nificance of differences in outcomes between the inter-
vention and control groups. The eight studies reported
results for a total of 15 different measures of clinical
outcome 9 measures of compliance, 2 measures of qual-
ity of life (QoL) and 13 other outcome measures.
The two health promotion & awareness interventions
targeted diabetic patients but none of the reported out-
come measures was available from both studies. In the
study by Balsa and Gandelman [25], where diabetic pa-
tients received a text message that intended to motivate
their use of a website, neither clinical outcomes nor
other outcomes were improved. In the study by Shetty
et al. [26], where patients received a text message with
advice on nutrition, physical activity and drug intake,
several clinical outcome measures showed significant
improvements, although compliance measures did not
improve significantly.
Out of the five studies evaluating tools for remote
monitoring and care support, one study evaluated an
interactive telephone-intervention for patients with dia-
betes [27]. Patients were advised to self-monitor their
Blood Glucose level and received therapeutic advice over
the phone twice a month. The study found that clinical
and compliance outcomes improved significantly more
strongly in the intervention group than in the control
group.
Two studies evaluated interactive mHealth interven-
tions for patients with asthma [28, 29], where patients
transmitted information about their pulmonary function
(as assessed by the peak expiratory flow rate, PEFR) to a
physician and received personalized therapeutic advice
(e.g., medication adjustments). Both studies found that
individuals showed improved pulmonary function tests
(FEV1% predicted and PEFR), although this finding was
not significant in the study by Ostojic et al. [29], which
included only a total of 16 participants. Liu et al. [28]
also found significant improvements of quality of life,
while Ostojic et al. [29] found significant improvements
of PEFR variability and of some self-reported clinical
outcome measures (e.g., coughing and night symptoms)
although not of others, and no effect on compliance.
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Table 1 Characteristics of the interventions
Intervention
Study name Used channel Received information Control group Timing Interactivity Personalization
Balsa and
Gandelman [25]
Internet platform & text
messages
New topics about type 2 Diabetes and
healthy lifestyle
Brief educational brochure Not reported No No
Shetty et al. [26] Text messages Medical nutrition therapy, physical activity
and drug intake reminders
Oral advises on diet modification
and physical activity
Once in three days No No
Liew et al. [30] Text messages Appointment reminder No reminder Once; 24–48 h before the
scheduled appointment
No Yes
Liu et al. [28] Interactive software on
cellphone
Adjustments of therapy Booklet for written asthma diary and
action plan
Immediately after the data has
been uploaded
Yes Yes
Ostojic et al. [29] Text messages Adjustments of therapy No weekly therapeutic advise Weekly Yes Yes
Piette et al. [23] Mobile blood pressure
monitor & phone calls
Advises and medication reminder No weekly therapeutic advise Weekly Yes Yes
Shahid et al. [27] Glucometer & Phone calls Adjustments of therapy Self monitoring with Glucometer
and regular follow up after 4 months
Every 15 days Yes Yes
Tian et al. [24] Smartphone application Advises on medication prescription and
lifestyle changes
Usual cardiovascular management
programs
Monthly No Yes
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Table 2 Study design characteristics of included RCTs
Study Location Income
group
Conditions Place of recruitment Inclusion criteria Sample size Mean Age
(Intervention;
control)
Planned
Follow-up
Measured
outcomes
Balsa and
Gandel-man [25]
Uruguay
(urban)
UMIC Type 2 Diabetes Waiting rooms of internists
treating diabetic patients
at three HMOs in Montevideo
Adult patients with Diabetes
2; Access to Internet (at least
once a week)
195 (intervention)
193 (control)
n/d 6 months Clinical,
Others
Shetty et al. [26] India (urban) LMIC Diabetes Patients at a diabetes centre
in Chennai
Type 2 Diabetes with a
minimum duration of 5 years;
Minimum of high school
Education; HbA1c value ranging
between 7 % to 10 %
110 (intervention)
105 (control)
50.1; 50.5 1 year Clinical,
Compliance
Liew et al. [30] Malaysia
(urban)
UMIC Different chronic
diseases
(mainly NCDs)
Two primary care clinics in
Kuala Lumpur
Registered with the clinics for at
least 6 months; return appointment
between 1 and 6 months;
ownership of a mobile phone
314 (telephone)
398 (text
mesages)
309 (control)
57.7; 58.1;
60.7
At least
6 months
Compliance
Liu et al. [28] Taiwan (urban) UMIC Asthma Outpatient clinics of Chang
Gung Memorial Hospital,
Linkou, northern Taiwan
Moderate to severe Asthma 43 (intervention)
46 (control)
54;
50
6 months Clinical,
Compliance,
QoL
Ostojic et al.
[29]
Croatia (urban) UMIC Asthma General Hospital “SvetiDuh”,
Zagreb
Moderate Asthma for at least 6
months; consistent access to a
cellphone, able to use text messages
8 (intervention)
8 (control)
24.5; 24.8 16 weeks Clinical,
Compliance,
Costs
Piette et al. [23] Honduras
(rural),
Mexico (urban)
UMIC, LMIC Hypertension Four private and two public
clinics in Cortes, Honduras
and one primary care center
in Real de Monte
SBP > = 130 mm Hg if diabetic and
SBP > = 140 mm Hg if non-diabetic;
between 18 and 80 years; access
to a cellphone and able to use it
89 (intervention)
92 (control)
58.0; 57.1 6 weeks Clinical,
Others
Shahid et al.
[27]
Pakistan (rural) LMIC Diabetes Department of Endocrinology,
Liaquat National Hospital
Patients between 18–70 years,
residing in rural areas of Pakistan,
HbA1c ≥ 8.0 % and having personal
functional mobile phone
220 (intervention)
220 (control)
48.95; 49.21 6 months Clinical,
Compliance
Tian et al. [24] China (rural),
India (rural)
UMIC, LMIC Cardiovascular
Diseases
CHWs at 27 villages from 15
townships in China and 20
villages in Haryana State, India
High cardiovascular risk individuals:
above 40 years and a self-reported
history of coronary disease
1095
(intervention);
991 (control)
59.7; 60.4 One year Clinical,
Compliance
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Table 3 Overview of intervention-group outcomes compared to control-group outcomes
Study Balsa and
Gandelman [25]
Shetty et al.
[26]
Shahid et al.
[27]
Ostojic et al.
[29]
Liu et al.
[28]
Piette et al.
[23]
Liew et al.
[30]
Tian et al. [24]
Intervention Health promotion &
awareness
Remote monitoring & care support Decision support
system
Personalization No Yes
Interactivity No Yes No
Disease Diabetes Asthma Hyper-
tension
Various
NCDs
CVDs
Clinical outcomes
SBPa (mm Hg), Mean +/− ++ + / ++b ++
Fasting blood glucose level +/−
BMIc, kg/m2 +/−d +/−e
PPGf < 180 mg ++
HbA1cg ++h ++i
TCj < 150 mg/dl ++
HDL-Ck > 40 mg/dl +/−
LDL-Cl < 100 mg ++ ++
FEV1%m, predicted + ++
PEFRn, L/min + ++
PEFRvariability ++
Coughing ++
Night symptoms ++
Wheezing +/−
Limitation of activities +/−
Compliance outcomes
Attendance + ++
ICSo dosage +/− +
Systemic steroids +/− +
Antileukotrienes +/− +/−
Long-acting beta2-agonist
Anti-hypertensive medication
use
++
Aspirin ++
Adherence to diet prescription +/− ++
Adherence to physical activity + ++
Quality of life related outcomes
Physical component ++
Mental component ++
Cost
Monetary -
Timely -
Other outcomes
Knowledge +/−
Perception of health quality +/−
Health-related behaviors +/−
Physician-Patient relationship +/−
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Piette et al. [23] found that their intervention provid-
ing personalized advice to hypertensive patients on the
basis of their self-recorded blood pressure lowered sys-
tolic blood pressure in the intervention group, although
this finding was significant only in a subgroup of 117
out of 181 participants with low literacy or high hyper-
tension information needs.
Liew et al. [30] found that text messages and telephone
appointment reminders lowered non-attendance of pa-
tients significantly when compared to controls.
The only study of a decision support system by Tian
et al. [24] found that medication compliance of patients
treated by CHWs, who were supported by smartphones,
increased significantly, and they had significantly lower
blood pressure when compared with controls.
The impact of mHealth on costs in terms of time and
money for physicians and patients was observed by only
one trial [29]. It was estimated that the intervention
would lead to additional monetary costs per patient of
€0.67 per week for text messages sent to physicians, and
that physicians spent 2 min per patient per week at a
cost of 1 Euro per patient.
Discussion
This is the first review focusing specifically on RCTs of
mHealth interventions against NCDs in LaMICs. Despite
much enthusiasm about the ‘great potential’ of mHealth
for addressing NCD needs in LaMICs and despite a
growing body of literature on the topic, we found only
eight studies that reported results of RCTs performed in
LaMICs. Except for one study [25], these showed gener-
ally positive effects of mHealth interventions on re-
ported outcome measures. However, because trials
tested different interventions (ranging from health pro-
motion over appointment reminders and medication ad-
justments to clinical decision support systems), and
included patients with different diseases (diabetes,
asthma, hypertension), and – partially as a result of this
– reported very different outcome measures, it is impos-
sible to generalize these findings.
Nevertheless, our review provides a first glimpse of the
slowly emerging evidence base on the effectiveness of
mHealth interventions for NCDs and has important im-
plications for policy-makers and researchers. First, it is
remarkable that the evaluated mHealth interventions
generally showed positive effects on reported outcome
measures, including clinical outcomes, compliance, and
quality of life. This finding is in line with findings from a
much broader literature on communicable disease and
maternal care, where many different kinds of mHealth
interventions have been found to improve clinical out-
comes and compliance of patients – although results
have been shown to vary depending on the specific type
of intervention [31–33].
Table 3 Overview of intervention-group outcomes compared to control-group outcomes (Continued)
Number of visits to emergency
department
++
Depression scores ++
Perceived overall health ++
Overall satisfaction with care ++
Medication problems ++
Current smoker, % +/−
Awareness of harms of high
salt diet, %
+/−
Receiving monthly follow-up, % ++
Hospitalization during the
past year, %
+
(+/−): no difference; (+): superior to control group without significance; (++): superior to control group with significance (p < 0.05); (−): inferior to control group. A
more detailed summary of reported outcomes, specifying values for intervention and control groups is available in Stephani et al. [44]
aSystolic Blood Pressure
bSubgroup of low-literacy people/people with higher education needs
cBody Mass Index
dBMI < 26
eBMI < 25
fPostprandial Plasma Glucose Test
gGlycated hemoglobin
hHbA1c < 8 %
imean HbA1c level
jTotal Cholestorol
kHigh-Density Lipoprotein Cholesterol
lLow Density Lipoprotein
mPeak Expiratory Flow Rate
nForced Expiratory Volume in 1 second
oInhaled Corticosteroid
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Second, our results suggest that particular types of
mHealth interventions that were found to have positive
effects on patients with communicable diseases and for
improving maternal care are likely to be effective also
for NCDs. For example, text message appointment re-
minders have been found to lead to higher pre-natal visit
rates of pregnant women [34–36], and two studies in-
cluded in our review show that they are also effective at
increasing attendance rates of patients with NCDs [26,
30]. Similarly, drug intake reminders have been found to
improve treatment adherence of people with AIDS and
Malaria [37–39], and one study in our review showed
that drug intake reminders (combined with other infor-
mation on medical nutrition and physical activity) im-
prove clinical outcomes of patients with Diabetes [26].
Third, our results show that there is very limited evi-
dence on the effects of mhealth in low income countries
as all included studies reported results of trials con-
ducted in middle income countries. Furthermore, when
considering the 4 broad categories of mHealth interven-
tions that we defined at the beginning, i.e., interventions
of 1) health promotion & awareness, 2) remote monitor-
ing & care support, 3) disease surveillance & outbreak
detection, and 4) decision support system, it is evident
that available RCTs have focused mostly on mHealth in-
terventions falling into category 2. Also Bloomfield et al.
[16] concluded that there is very limited evidence con-
cerning a wide range of health systems challenges, which
could potentially be addressed by the implementation of
mHealth interventions. In our review, several studies
evaluating clinical decision support systems were identi-
fied during full-text screening [40–43] but they had to
be excluded because they were no RCTs. Information on
cost-effectiveness of mHealth interventions is largely un-
available and only one study included in our review con-
sidered the effect of mHealth on costs of care [29].
An important limitation of our review is that we ex-
cluded all studies that did not report results of RCTs.
Observational studies and non-randomized trials may
provide important bits of information that are useful for
understanding the effectiveness of mHealth. Neverthe-
less, we opted for excluding these studies as non-
randomized trial designs carry a greater risk of being
flawed as a result of multiple biases [22]. Another limita-
tion of the review process could have been the restriction
to the two languages German and English. Furthermore,
given the limited number of studies, it was not possible to
compare results of different studies. Effects of mHealth are
likely to differ depending on the specific type of interven-
tion, the specific disease, and the specific context. Conse-
quently, it is impossible to draw firm conclusions on the
effectiveness of mHealth interventions in general, e.g., by
carrying out pooled analyses of outcome data. Finally, the
specific effects of different kinds of mHealth interventions
on different kinds of patients with NCDs living in LaMIC
could not be investigated. For example, it is likely that the
effectiveness of interventions depends on whether patients
can interact with health professionals and whether infor-
mation is personalized to the patients. Although our review
includes studies with both interactive and non-interactive
interventions as well as studies with both personalized and
non-personalized information, the specific effects of these
different interventions could not be compared because
they were provided to different patients (in difference set-
tings) and reported different outcome measures.
Conclusion
Our review shows that there are only eight studies
reporting results of RCTs of mHealth interventions for
patients with NCDs in LaMICs. These have generally
found positive results. However, a more detailed analysis
of the specific effects of different types of mHealth inter-
ventions on different types of patients and a firm conclu-
sion about the effectiveness of mHealth against NCDs is
impossible because of the small number of studies and
the heterogeneity of reported outcome measures.
Nevertheless, our results indicate that some findings
of the positive effects of mHealth interventions for pa-
tients with communicable diseases and for maternal care
can be replicated by mhealth interventions for patients
with NCDs. However, we can only repeat the conclu-
sions of previous reviews [15, 16] that more research is
needed to fill the many gaps in knowledge about
mHealth interventions for NCDs in LaMICs.
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